UK Govt Under Fire From Pharma Industry Over Statutory Pricing Scheme Changes

 
• By Eliza Slawther
  
Miscalculation
ABPI: The DHSC miscalculated the costs and benefits of its proposed statutory scheme changes • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Europe

More from Geography